Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Abstract

Ovarian cancer causes more deaths than any other gynecologic malignancy in developed countries. Sixteen million sequence variants, identified through whole-genome sequencing of 457 Icelanders, were imputed to 41,675 Icelanders genotyped using SNP chips, as well as to their relatives. Sequence variants were tested for association with ovarian cancer (N of affected individuals = 656). We discovered a rare (0.41% allelic frequency) frameshift mutation, c.2040_2041insTT, in the BRIP1 (FANCJ) gene that confers an increase in ovarian cancer risk (odds ratio (OR) = 8.13, P = 2.8 × 10(-14)). The mutation was also associated with increased risk of cancer in general and reduced lifespan by 3.6 years. In a Spanish population, another frameshift mutation in BRIP1, c.1702_1703del, was seen in 2 out of 144 subjects with ovarian cancer and 1 out of 1,780 control subjects (P = 0.016). This allele was also associated with breast cancer (seen in 6/927 cases; P = 0.0079). Ovarian tumors from heterozygous carriers of the Icelandic mutation show loss of the wild-type allele, indicating that BRIP1 behaves like a classical tumor suppressor gene in ovarian cancer.

Similar articles

See all similar articles

Cited by 136 articles

See all "Cited by" articles

References

    1. Cancer Cell. 2005 Sep;8(3):255-65 - PubMed
    1. Nat Genet. 2008 Sep;40(9):1068-75 - PubMed
    1. Nat Genet. 2010 Oct;42(10):874-9 - PubMed
    1. Nat Genet. 2006 Nov;38(11):1239-41 - PubMed
    1. Eur J Cancer. 2004 Dec;40(18):2788-93 - PubMed

Publication types

Substances

Associated data

Feedback